Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07632898 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
484
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Inhibikase Therapeutics